Research & Clinical Trials – Page 5
-
Research & Clinical TrialsLate-stage patients with pleural mesothelioma have survived longer than anticipated — with good quality of life — in a phase I clinical…
-
Research & Clinical Trials
Carbone: Building the Guide to BAP1 Mutation in Mesothelioma
Over the years, I have “collected” many families affected by the BAP1 cancer syndrome, a novel medical condition we discovered in 2011. Pathogenic germline… -
Research & Clinical Trials
Targeted Therapy Making Progress with Pleural Mesothelioma
Future treatment of pleural mesothelioma cancer continued its move toward a more personalized, targeted approach with the latest results from a multi-center clinical… -
Research & Clinical Trials
New Mesothelioma Immunotherapy Clinical Trial Opens at MD Anderson
The acclaimed MD Anderson Cancer Center in Houston is opening a phase II clinical trial involving a new immunotherapy drug aimed specifically at… -
Research & Clinical Trials
Heated Intrathoracic Chemotherapy Could Extend Mesothelioma Survival
Patients with pleural mesothelioma undergoing aggressive surgery should consider combining it with controversial hyperthermic intrathoracic chemotherapy to extend survival, according to a recent… -
Research & Clinical Trials
Study Finds Benefits to Second Peritoneal Mesothelioma Surgery
Patients with peritoneal mesothelioma cancer can survive considerably longer if they are willing and able to undergo a second aggressive surgery following tumor… -
Research & Clinical Trials
Mesothelioma Clinical Trial Matches Treatment to Genetic Profiles
Scientists at the University of Leicester in the United Kingdom recently published phase 2 clinical trial results involving abemaciclib, a new genetic therapy for… -
Research & Clinical Trials
NCI Moving Closer to More Effective Treatment for Pleural Mesothelioma
A research team at the National Cancer Institute is developing a novel therapy that could change the treatment paradigm for pleural mesothelioma. -
Research & Clinical Trials
NCI Opens New Immunotherapy Clinical Trial for Mesothelioma
The National Cancer Institute has opened a promising clinical trial aimed at increasing the effectiveness of immunotherapy treatment for patients with unresectable malignant… -
Research & Clinical Trials
Clinical Trials Lead to Promising Updates in Mesothelioma Immunotherapy
Researchers have made significant progress in mesothelioma treatment advancements recently, including promising work with immunotherapy. The first U.S. Food and Drug Administration-approved combination…